Zivo Bioscience, Inc.

Zivo Bioscience, Inc. is a research and development company operating in the biotech and agtech sectors. The company's intellectual property portfolio includes proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Zivo Bioscience focuses on its proprietary algal culture and materials derived from it, which are believed to offer benefits for animal and human health, primarily through inflammation-modulating and immune-boosting properties. The company's efforts are centered on two main initiatives. The first involves identifying bioactive extracts or novel bioactive molecules from its proprietary algal culture to treat various diseases. The second initiative focuses on utilizing the proprietary algal culture in its whole form as a food product to leverage its nutritional value. In the first quarter of 2022, Zivo Bioscience reformulated its biotech and agtech businesses around these two concepts, developing a focused strategy for each business after reviewing market potential, scale, profit, and associated technical and business risks.